- Home
- / StemRIM
StemRIM
Stock Price
¥375
2024-10-29
Market Capitalization
¥22.6 B
2024-10-29
StemRIM Summary
Company Summary
- Overview
- StemRIM (株式会社ステムリム) is a biotechnology company that develops regenerative medicines. It offers autologous cell sampling devices for medical treatment. The company also provides peptide formulations and stem cell gene therapy services.
- Type
- Public
- Status
- Active
- Founded
- 2006
- HQ
- Ibaraki, JP | view all locations
- Website
- http://stemrim.com/english/
- Cybersecurity rating
Table of Contents
LocationsView all
1 location detected
Ibaraki, Osaka HQ
Japan
Saitoasagi, 5-chōme-1 Saitoasagi
StemRIM Financials
Summary Financials
- Gross profit (H1, 2026)
- ¥11.0M
- Net income (H1, 2026)
- (¥928.6M)
- Cash (H1, 2026)
- ¥6.2B
- EBIT (H1, 2026)
- (¥950.2M)
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026